NCT00482950

A Study to Evaluate Safety and Efficacy of PHX1149T in Subjects With Type 2 Diabetes Mellitus

A Phase 2b, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate Safety and Efficacy of PHX1149T in Subjects With Type 2 Diabetes Mellitus

• Status: Unknown
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 400 (estimated)
• Sponsor: Phenomix · Industry
• Sex: All
• Age: 18 Years – 75 Years
• Healthy volunteers: Not accepted

Summary

This study is to test the efficacy and safety of PHX1149T in combination with metformin, a glitazone, or metformin and a glitazone in subjects with Type 2 diabetes for 12 weeks. After completing the 12 week double blind part of the study, subjects can enter an open label extension study

Conditions

• Type 2 Diabetes Mellitus

Interventions

Type	Name	Description
DRUG	PHX1149T

Timeline

• Start date: 2007-04-01
• Completion: 2008-02-01
• First posted: 2007-06-06
• Last updated: 2009-06-08

Locations

26 sites across 5 countries: United States, Argentina, Canada, India, Mexico